Despite the availability of multiple antihypertensive therapies, many patients remain unable to achieve adequate blood pressure control. Excess aldosterone is a key contributor to resistant and uncontrolled hypertension. Baxdrostat (Baxfendy ® ), a first-in-class selective aldosterone synthase (CYP11B2) inhibitor, was approved on May 15, 2026, for use in adults with inadequately controlled hypertension receiving other antihypertensive medications. Unlike mineralocorticoid receptor antagonists, baxdrostat reduces aldosterone biosynthesis while preserving cortisol production, offering a distinct mechanism of action. In phase 3 clinical trials, once-daily baxdrostat (1–2 mg) produced placebo-adjusted reductions of ~ 9–10 mmHg in seated systolic blood pressure. Hyperkalemia was generally manageable, with no clinically meaningful cortisol suppression observed. These findings support baxdrostat as a promising new option for patients with difficult-to-control hypertension.
Purpose The engineered v5.9 DNA polymerase has been reported to exhibit enhanced thermostability in loop-mediated isothermal amplification (LAMP). As an initial step toward field-deployable molecular diagnosis of giardiasis, we...
Background Polygenic risk scores for cardiovascular disease show poor agreement between methods, and most treat sex as a covariate rather than stratifying by it, despite well-documented sex differences in disease incidence and outcomes....
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02013-7 The authors identify the mitochondrial RNA methyltransferase, NSUN4 as a potential therapeutic target in intrahepatic cholangiocarcinoma, with...
Communications Medicine, Published online: 19 November 2026; doi:10.1038/s43856-026-02009-3 People with type 2 diabetes can have too much sugar in their blood stream, which can lead to health problems. Metformin is a common medication...
Cognitive tests are commonly used to evaluate the effects of cognitive and exercise interventions in Parkinson’s disease, but their ability to distinguish genuine change from measurement variability remains insufficiently characterized....